检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]华东师范大学生命科学学院,上海200062 [2]中国科学院上海药物研究所国家新药筛选中心,上海201203
出 处:《生物技术通报》2012年第4期135-140,共6页Biotechnology Bulletin
基 金:国家重大科学研究计划蛋白质专项(2007CB914201);上海市公共服务平台项目(09DZ2291200)
摘 要:在研究AMPK的调控网络时,通常利用过表达显性失活突变型AMPK(dominant negative AMPK,DN-AMPK)作为研究手段来验证AMPK在某些重要生理病理调节通路中的关键作用。旨在利用Ad5腺病毒载体体系构建Ad-DN-AMPK表达载体,并在成肌细胞系C2C12中检测无活性AMPK高表达后对C2C12细胞分化为肌管细胞的影响。通过构建AMPKα1(D159A)和AMPKα2(K45R)的腺病毒表达载体,在HEK293细胞中成功包装并扩增出完整的腺病毒,待其感染能力基本稳定后,将腺病毒感染C2C12,利用激光定量成像仪检测其感染滴度,感染效率能高达100%,并且能够持续表达6 d。DN-AMPK高表达后,AMPK常用激活剂A769662(SN-5)不能激活AMPK,表现为AMPK下游蛋白活性丧失,如ACC磷酸化无变化。通过实时定量PCR的方法,检测DN-AMPK对C2C12分化为肌管细胞的影响,结果表明过表达DN-AMPK能够促进C2C12细胞分化为肌管细胞的标记蛋白(Myod和Myogenin)的表达,即促进C2C12分化为肌管细胞。In order to evaluate the potency of AMPK,usualy we use dominant negative AMPK(DN-AMPK)as a tool.For this reason,we constructed recombinant adenovirus expression vector of DN-AMPK(AMPKα1(D159A)and AMPKα2(K45R)),which were transfected into mouse myoblast cell line C2C12 to detect the regulation of DN-AMPK during the C2C12 myotube differentiation.The recombinant plasmid was packaged and amplified after being transfected into HEK293 cells.After infecting C2C12 myoblast with recombinant adenovirus vector,the adenoviral infection was determined by iCys Research Imaging Cytometer.The infection efficiency was almost 100% for 6 days and Western blot indicated that the expression of AMPK in C2C12 of recombinant adenoviral infection group was signifcantly higher than the control group.At the same time,when DN-AMPK was overexpressed,SN-5(AMPK activator)could not induce activation of ACC.During the differentiation of C2C12 myoblast,DN-AMPK can increase the expression of Myod and Myogenin(myotube marker).These results indicated that the overexpression of DN-AMPK could increase the level of differentiation of C2C12 into myotube.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15